Brief: Sedana Medical Receives IND Approval For U.S. Trials
Dec 23 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL RECEIVES IND APPROVAL FOR US TRIALS
Source text for Eikon: ID:nWkr1RkBgv
Further company coverage: SEDANA.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln